Well Told Grants

Federal grant recipients / Arizona

Federal grants to Faknostics LLC

Phoenix, Arizona · Small businesses · UEI TK5AKDP8CSZ7

Faknostics LLC in Phoenix, Arizona received $4.6 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Cancer Biology Research, with $2.0 million. In fiscal 2025 it was awarded $1.3 million.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Faknostics LLC by fiscal year
Fiscal yearAwardsAmount
FY 20211$674,537
FY 20222$970,661
FY 20231$654,706
FY 20242$999,772
FY 20252$1.3 million

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Faknostics LLC

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Cancer Biology Research 93.3961$2.0 million
Cardiovascular Diseases Research 93.8372$1.6 million
Diabetes, Digestive, and Kidney Diseases Extramural Research 93.8471$989,753

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services4$4.6 million

Largest awards

The 4 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Development of non-catalytic peptide inhibitors of focal adhesion kinase (FAK) for use in melanoma - abstract melanoma is the deadliest form of skin cancer, affecting an estimated 1.2 million americans. The disease has a high propensity for dissemination, and metastatic melanoma has a dismal prognos
ASST_NON_R42CA240124_075 on USAspending
Cancer Biology ResearchAugust 12, 2021$2.0 million
Non-catalytic fak inhibitors as novel therapeutics for lung fibrosis - project abstract idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive and fatal fibrotic lung disorder which disproportionately affects men and the elderly. Although two drugs (pirfenidone and nintedanib) have recent
ASST_NON_R42HL162392_075 on USAspending
Cardiovascular Diseases ResearchAugust 30, 2024$1.3 million
Novel paxillin-fak inhibitors for the treatment of liver fibrosis - abstract chronic liver diseases like metabolic dysfunction-associated steatohepatitis (MASH), alcoholic liver disease (ALD), and viral hepatitis afflict more than 4.5 million americans and are a major cause of death in those over 45
ASST_NON_R42DK141379_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchSeptember 6, 2024$989,753
Non-catalytic fak inhibitors as novel therapeutics for lung fibrosis - project abstract idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive and fatal fibrotic lung disorder which disproportionately affects men and the elderly. Although two drugs (pirfenidone and nintedanib) have recent
ASST_NON_R41HL162392_075 on USAspending
Cardiovascular Diseases ResearchAugust 9, 2022$299,905

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Faknostics LLC get?

$4.6 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Faknostics LLC the most?

The Department of Health and Human Services, with $4.6 million in 4 awards.

What is Faknostics LLC's largest federal grant?

$2.0 million under Cancer Biology Research, with its first action in the period on August 12, 2021. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Faknostics LLC?

Its largest are Cancer Biology Research, Cardiovascular Diseases Research and Diabetes, Digestive, and Kidney Diseases Extramural Research.

Other grant recipients in Phoenix

Largest federal grant recipients in Arizona · Federal grants in Arizona